Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for WAVE Life Sciences Ltd. (WVE : NSDQ)
 
 • Company Description   
WAVE Life Sciences Pte. Ltd. is a preclinical biopharmaceutical company. It designs, develops and commercializes nucleic acid therapeutic candidates for Huntington's disease, Duchenne muscular dystrophy and inflammatory bowel disease. Huntington's disease, the Company has programs targeting HTT SNP-1 and HTT SNP-2; DMD, targeting Exon 51 and in IBD, it is targeting SMAD7. The Company has late-stage discovery programs in epidermolysis bullosa simplex, in which it is targeting KRT14 SNP-1 and KRT14 SNP-2 and in DMD, it is focused on an additional DMD target, Activin Receptor type IIb. WAVE Life Sciences Pte. Ltd. is based in Singapore.

Number of Employees: 288

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.85 Daily Weekly Monthly
20 Day Moving Average: 2,177,839 shares
Shares Outstanding: 159.14 (millions)
Market Capitalization: $1,249.25 (millions)
Beta: -1.37
52 Week High: $16.74
52 Week Low: $5.28
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 14.93% 13.60%
12 Week -5.65% -10.76%
Year To Date -36.54% -44.58%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
7 STRAITS VIEW #12-00 MARINA ONE EAST TOWER
-
SINGAPORE,U0 018936
SGP		 ph: 65-6236-3388
fax: 617-949-2901		 investorrelations@wavelifesci.com http://www.wavelifesciences.com
 
 • General Corporate Information   
Officers
Paul B. Bolno - Chief Executive Office; President and Director
Christian Henry - Chairman of the Board of Directors
Kyle Moran - Chief Financial Officer
Aik-Na Tan - Director
Adrian Rawcliffe - Director

Peer Information
WAVE Life Sciences Ltd. (CORR.)
WAVE Life Sciences Ltd. (RSPI)
WAVE Life Sciences Ltd. (CGXP)
WAVE Life Sciences Ltd. (BGEN)
WAVE Life Sciences Ltd. (GTBP)
WAVE Life Sciences Ltd. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: Y95308105
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/11/25
Share - Related Items
Shares Outstanding: 159.14
Most Recent Split Date: (:1)
Beta: -1.37
Market Capitalization: $1,249.25 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.27 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.16 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/11/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 8.97
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -24.00%
vs. Previous Quarter: -6.90%
Sales Growth
vs. Year Ago Period: -55.82%
vs. Previous Quarter: -5.19%
ROE
09/30/25 - -
06/30/25 - -78.45
03/31/25 - -86.49
ROA
09/30/25 - -
06/30/25 - -41.51
03/31/25 - -37.20
Current Ratio
09/30/25 - -
06/30/25 - 2.56
03/31/25 - 2.95
Quick Ratio
09/30/25 - -
06/30/25 - 2.56
03/31/25 - 2.95
Operating Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Net Margin
09/30/25 - -
06/30/25 - -
03/31/25 - -
Pre-Tax Margin
09/30/25 - -
06/30/25 - -138.24
03/31/25 - -107.04
Book Value
09/30/25 - -
06/30/25 - 0.88
03/31/25 - 1.12
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - -
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - -
06/30/25 - 5.35
03/31/25 - 4.38
 

Powered by Zacks Investment Research ©